 |
|
|
|
|
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Roy S. on PAPER: Nalls MA. et al., 2013, This study confirms links between dementia with Lewy bodies (DLB) and glucocerebrosidase (GBA)... 22 Apr 2013.
|
|
|
 |
|
|
Roy S. on PAPER: Lim Y. et al., 2011, Deciphering details of α-synuclein-induced pathology in the brain has been surprisingly... 8 Jul 2011.
|
|
|
|
|
|
Roy S. on PAPER: Mazzulli JR. et al., 2011, Nice study by Mazzuli et al. linking glucocerebrosides to α-synuclein. 1 Jul 2011.
|
|
|
|
|
|
Roy S. on PAPER: Igaz LM. et al., 2011, Wonderful, rigorous study, and perhaps a window into the future of neurodegeneration research.... 26 Jan 2011.
|
|
|
|
|
|
Roy S. on NEWS: α-Synuclein’s Day Job: To Chaperone SNARE Complexes?, By directly examining SNARE assembly, Burre et al. present good evidence that α-synuclein plays... 21 Oct 2010.
|
|
|
|
|
|
Roy S. on NEWS: Excess α-Synuclein Sends Synapses Sputtering, Our goal in this study was to try connecting the dots between two key pathologic events:... 18 Jun 2010.
|
|
|
|
|
|
Roy S. on NEWS: The Many Misdeeds of Aβ—Seizures and Axonal Transport Interference, The study by Pigino et al. study elegantly highlights a possible mechanism by which Aβ oligomers... 8 Apr 2009.
|
|
|
|
|
|
Roy S. on NEWS: Paris: Intracellular Traffic and Neurodegenerative Disorders, This article reiterates the critical importance of studying AD in the context of the... 9 Jul 2008.
|
|
|
|
|
|
Roy S. on NEWS: Dopaminergic Transplants—Stable But Prone to Parkinson’s?, These studies elegantly demonstrate that transplanted fetal grafts can survive and thrive in... 15 Apr 2008.
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
